Recently, tumor vaccines are becoming a hot topic in tumor immunotherapy, and the primary tumor vaccines carried out against OCCC are Glypcan-3 (GPC3), a member of the Glypcan family acetyl heparan sulfate protein glycoprotein family, which is overexpressed in OCCC [145, 158]. Here, GPC3 is linked to neoplasm.